situ hibridizasyon yöntemi i - Çukurova Üniversitesi

85. W. H. Clark Jr., L. From, E. A. Bernardino, and M. C. Mihm, The histogenesis and biologic
behavior of primary human malignant melanomas of the skin, Cancer Research, vol. 29, no. 3, 1969:
pp. 705–727,
86. R.J. Reed, Acral lentiginous melanoma in New Concepts in Surgical Pathology of the Skin, New
York: Wiley, NY, USA, 1976: pp. 89–90
87. T. Demitsu H. et al., Melanoma in situ of the penis, Journal of the American Academy of
Dermatology, vol. 42, no. 2, 2000: pp. 386–388
88. DJ Ruiter, MC van Dijk and CM Ferrier, Current diagnostic problems in melanoma pathology.
Semin Cutan Med Surg, 22 2003: pp. 33–41.
89. In: Mooi W, Krausz T (eds). Biopsy: Pathology of Melanocytic Disorders. London: Chapman &
Hall 1992: pp 156–185.
90. Mooi WJ, Krausz T. Biopsy Pathology of Melanocytic Disorders. London: Chapmann & Hall
Medical, 1992: pp. 304-323.
91. Greene FL at al. AJCC Cancer Staging Manual, Sixth Ed., New York: Springer Verlag, 2002:
pp.209-217
92. Balch CM et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol.
2009; 27: 6199–206.
93. Zettersen E at al. Prognostic Factors in primary cutaneous melanoma. Surg Clin North Am 2003;
83: 61-75
94. Cochran AJ at al. İndividualized prognozis for melanoma patients. Human Pathol. 2000; 31: 327-
331
95. Crowson AN, at al. The melanocytic Proliferations, New York: Wiley- Liss, 2001.
96. Mooi WJ, Krausz T. Biopsy Pathology of Melanocytic Disorders. London: Chapmann & Hall
Medical, 1992; pp. 304-323.
97. Lui V, Mihm MC. Pathology of malignant melanoma. Surg Clin Am. 2003; 83: 31-60
98. Arlo J. Miller, M.D., Ph.D., and Martin C. Mihm, Jr., M.D. Melanoma N Engl J Med 2006;
355:51-65
99. Dahl C, Guldberg P. The genome and epigenome of malignant melanoma. APMIS 2007; 115:
1161–1176.
98